Strategies to Remove Pre-Existing AAV Antibodies: IgG Enzymatic Degradation vs FcRn Inhibition. Presented by Yash Shah, PhD, ...

FORE Biotherapeutics has announced that its plixorafenib abstract has been selected for poster presentation at the highly ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened ...

Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid ...

The annual event for the military medical research and development community had another successful year as a record 800 ...

Manchester University's annual Student Symposium, showcasing undergraduate and graduate scholarly work across disciplines, was April 23.